Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
76°
Partly Cloudy
Site search
Search
Menu
Subscribe
Home
News
Local News
Sports
Obituaries
Photos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Explore the Sheyenne
Best of 2023
Archives
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
India Globalization Capital Inc
(NY:
IGC
)
0.3690
-0.0063 (-1.68%)
Official Closing Price
Updated: 8:00 PM EDT, Aug 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about India Globalization Capital Inc
< Previous
1
2
3
Next >
IGC Stock Earnings: IGC Pharma Beats EPS, Misses Revenue for Q1 2025
August 12, 2024
IGC stock results show that IGC Pharma beat analyst estimates for earnings per share but missed on revenue for the first quarter of 2025.
Via
InvestorPlace
IGC Pharma Revenue Declines 51% YoY Due To Completion Of Its Legacy Project In India, Highlights Important Milestones In Alzheimer's Research
August 09, 2024
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
June 25, 2024
Pre-market stock movers are worth checking out on Tuesday as we get into all of the hottest news worth reading about this morning!
Via
InvestorPlace
IGC Stock Earnings: IGC Pharma Meets EPS, Beats Revenue for Q4 2024
June 24, 2024
IGC stock results show that IGC Pharma met analyst estimates for earnings per share but beat on revenue for the fourth quarter of 2024.
Via
InvestorPlace
Hedge Fund Settles At $2.25M With SEC For Exposed Short Seller Deal, 2 Cannabis Stocks Affected
June 13, 2024
Discover how Anson Funds settled with the SEC for $2.25M over an undisclosed collaboration with short seller impacting cannabis stocks
Via
Benzinga
Topics
Cannabis
Regulatory Compliance
Exposures
Cannabis
Legal
Regulatory
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
June 11, 2024
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
June 04, 2024
Via
Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
May 31, 2024
Via
Benzinga
6.7 Million Americans Live With Alzheimer’s – IGC Pharma Believes They Deserve Treatment Options Without Black Box Warnings
May 09, 2024
6.7 Million Americans Live With Alzheimer’s – IGC Pharma Believes They Deserve Treatment Options Without Black Box Warnings
Via
News Direct
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
May 01, 2024
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
May 01, 2024
It's time to dive into the biggest pre-market stock movers as we check out all of the hottest news for Wednesday morning!
Via
InvestorPlace
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
April 29, 2024
Pre-market stock movers are a great way to start the week as we check out all of the biggest news moving shares on Monday!
Via
InvestorPlace
12 Health Care Stocks Moving In Tuesday's After-Market Session
April 16, 2024
Via
Benzinga
IGC Pharma Says Cannabinoid-Based Drug Candidate Provides Fast Relief With Fewer Side Effects For Alzheimer's-Associated Agitation
April 16, 2024
IGC Pharma shares encouraging interim data from Phase 2 trial of IGC-AD1 for Alzheimer's agitation. Results suggest significant reduction in agitation with minimal side effects compared to placebo.
Via
Benzinga
Who's Who In Cannabis: Latest Executive Changes You Should Know About
April 15, 2024
Via
Benzinga
IGC Pharma Releases Positive Interim Analysis Of Its Ongoing Phase 2 Trial In Alzheimer's Research
April 03, 2024
--News Direct--
Via
News Direct
IGC Pharma Releases Positive Interim Analysis Of Its Ongoing Phase 2 Trial In Alzheimer's Research
April 02, 2024
Via
Benzinga
EXCLUSIVE: Revolutionary Alzheimer's Drug By IGC Shows Early Success
March 20, 2024
IGC Pharma's breakthrough Alzheimer's drug, IGC-AD1, shows promising interim results in reducing cognitive and behavioral symptoms, offering hope for patients and families. Its dual-action capability...
Via
Benzinga
Alzheimer's-Focused Small Cap Firm IGC Pharma Releases Data, Candidate Reduces Agitation Compared To Placebo
March 20, 2024
IGC Pharma unveils interim results of Phase 2 trial of IGC-AD1 for Agitation in Alzheimer's Dementia. Shows reduction in agitation vs. placebo observed.
Via
Benzinga
Benzinga's 2024 Virtual Healthcare: What's Next In Health?
March 19, 2024
The 2024 Benzinga Virtual Healthcare Summit brings together top healthcare professionals and companies to discuss industry trends, advancements in technology, and the future of healthcare. Don't miss...
Via
Benzinga
IGC Pharma Advances In Alzheimer's Research From Pre-clinical Studies To Phase Two Trial With Its Novel Therapy Candidate IGC-AD1
March 19, 2024
--News Direct--
Via
News Direct
12 Health Care Stocks Moving In Wednesday's After-Market Session
February 28, 2024
Via
Benzinga
IGC Pharma Announces Q3 2024 Earnings: Strategic Patent Achievements Propel Forward Amid Losses
February 19, 2024
IGC Pharma's Q3 2024 results: Navigating financial dips with strategic patents in pain treatment and Alzheimer's therapy.
Via
Benzinga
Topics
Intellectual Property
Exposures
Intellectual Property
Why IGC Pharma Stock Is Moving Higher
January 23, 2024
IGC Pharma highlighted data from a trial in which the group treated with TGR-63 showed a 78% and 85% reduction in the cortical and hippocampal amyloid load, respectively, reaffirming its potential to...
Via
Benzinga
AI And THC: IGC Pharma Teams Up With Colombian University For Alzheimer's Treatment Research
November 21, 2023
IGC Pharma partners with University of Los Andes, to leverage AI for improving Alzheimer's disease treatment and clinical trial efficiency.
Via
Benzinga
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Cannabis Based Pain Relief Solution Receives European Patent Approval
October 20, 2023
IGC Pharma, Inc. (NYSE American: IGC) has been granted European Patent No. 3193862 by the European Patent Office for its innovative "Cannabinoid Composition and Method for Treating Pain."
Via
Benzinga
Topics
Cannabis
Intellectual Property
Exposures
Cannabis
Intellectual Property
12 Health Care Stocks Moving In Thursday's After-Market Session
September 21, 2023
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
September 12, 2023
Via
Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
September 01, 2023
Via
Benzinga
IGC Pharma FY23 Revenue Grows 129%, What About Net Loss?
July 12, 2023
IGC Pharma, Inc. (AMEX:IGC) released its financial results for the fiscal year ended March 31, 2023, revealing revenue of $911,000, an increase of 129% compared to $397,000 in fiscal year 2022. FY 2023...
Via
Benzinga
< Previous
1
2
3
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.